Glad to see that Jason has ramped up the LYMPRO revenue projections from One Million to Twenty million, quite a move! The fact that he has reconsidered his earlier estimates will catch the attention of some investors and is clearly very positive for AMBS. As he stated, Gerald just has to deliver on the milestones! Jan. 14 is going to be an important date for the BP community re. LYMPRO. We have all been saying this for a weeks now, if not months, just too many positive going on to risk being on the sideline here! Great to see this, thanks Zoom!
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links